Clinical trial

Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)

NCT00139932

Study summary

ClinicalTrials.gov

Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record formoterol fumarate Normalized identity: formoterol fumarate View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-09-01

PhasePHASE4

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

formoterol fumarateDRUG · verified · RxNorm: formoterol fumarate

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Integrated Therapeutics Groupcollaborator

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00139932 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.